Core Insights - The construction of a national-level trusted data space for the pharmaceutical industry will follow three main strategies: government-enterprise co-management, pilot projects in subspaces, and a whitelist approach for gradual implementation [1][2] Group 1: Data Governance in Pharmaceutical Industry - The trusted data space is based on the drug traceability platform launched in 2023, which integrates data across the entire chain of drug production, distribution, and usage [1] - The focus will initially be on mature areas such as biological products, medical devices, and anesthetic drugs, with steady progress being made in these areas [1] Group 2: AI and Healthcare - Key breakthrough areas for AI in healthcare include innovative drug development, intelligent health management, and medical diagnostic assistance [1] - The potential for AI to enhance health management services and reduce misdiagnosis rates is significant, facilitated by the integration of health data [1] Group 3: Collaboration with Guizhou - The company anticipates that the Digital Expo will play a role in policy guidance, standard setting, and ecosystem collaboration within the healthcare big data sector [2] - Future collaboration with Guizhou will focus on integrating industry data spaces with urban data spaces and implementing a personal health account system [2]
陈曦：推进药品可信数据空间建设 探索“AI+医疗”落地
Zhong Guo Jing Ji Wang·2025-08-30 08:02